About
1.89USD+0.08 +4.42%
Closed • Updated at 12:34 GMT+00:00Market Cap$340.37M
Volume3.81M
Beta0.61
RSI28.51
Compass Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 5 2026
Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update
Apr 24 2026
Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer
Mar 5 2026
Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update
Jan 6 2026
Compass Therapeutics Provides Corporate Update
Jan 5 2026
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Google Übersetzer